首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Application of lipid as emulsifier in the solvent evaporation technique in fabrication of polymeric nanospheres for controlled release of Taxol
【24h】

Application of lipid as emulsifier in the solvent evaporation technique in fabrication of polymeric nanospheres for controlled release of Taxol

机译:脂质作为乳化剂在溶剂蒸发技术中的应用衍生蒸发技术,其紫杉醇控制释放

获取原文

摘要

This study was intended to examine the potential of application of 1,2-dipalmitoylphosphatidyl-choline (DPPC) as an emulsifier in the solvent evaporation technique, which is one of the most widely used methods to prepare polymeric microspheres and nanospheres for controlled release of an effective anticancer drug Paclitaxel (Taxol/sup (R)/). The poly(D,L-lactic-co-glycolic acid) (PLGA, 75/25) nanospheres loaded with Taxol were prepared by the solvent evaporation technique with DPPC and/or poly(vinylalcohol) (PVA) as emulsifier(s). The fabricated nanospheres in various conditions were characterized by SEM and laser light scattering, which revealed that the size of nanospheres ranged from 400 to 900 nm. The encapsulation efficiency was measured by HPLC. The result showed that nanospheres fabricated with DPPC as emulsifier have higher encapsulation efficiency than those with PVA. It was also demonstrated that the EE of nanospheres fabricated with both DPPC and PVA as emulsifiers is higher than those of nanospheres with DPPC or PVA as emulsifier alone, which suggested that a synergetic effect may exist between PVA and DPPC. The surface property of nanospheres containing DPPC was also studied by XPS, which showed dominance of DPPC on the nanospheres surface. XPS study and the in vitro release experiment suggest that nanospheres fabricated with DPPC can be an improved drug delivery system.
机译:本研究旨在研究溶剂蒸发技术中1,2-Dipalmitoylphosphatidyl胆碱(DPPC)作为乳化剂的施加潜力,这是制备聚合物微球和纳米球的最广泛使用的方法之一有效的抗癌药物紫杉醇(紫杉醇/ sup(r)/)。通过用DPPC和/或聚(乙烯醇)(PVA)作为乳化剂制备含有紫杉醇的聚(D,L-乳酸二乙醇酸)(PLGA,75/25)纳米球,作为乳化剂制备。通过SEM和激光散射的特征在各种条件下制造的纳米球,这揭示了纳米球的尺寸范围为400至900nm。通过HPLC测量封装效率。结果表明,用DPPC制造的纳米球与乳化剂具有比具有PVA的封装效率更高。还证明,用DPPC和PVA制造的纳米球的EE作为乳化剂高于单独的乳化剂的DPPC或PVA的纳米球,这表明PVA和DPPC之间可能存在协同效应。还通过XPS研究了含有DPPC的纳米球的表面特性,XPS在纳米球表面上显示了DPPC的优势。 XPS研究和体外释放实验表明,用DPPC制造的纳米球可以是改进的药物输送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号